Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,096 public trials 1,232 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Active, Not Recruiting

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

NCT05664243

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Louisville Hospital/James Graham Brown Cancer Center Louisville, Kentucky, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

TH1902 in Patients With Advanced Solid Tumors

NCT04706962

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Pennsylvania Cancer Specialists Research Institute Gettysburg, Pennsylvania, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)

NCT04164901

Conditions
Glioma, Grade 2 Glioma, Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
  • UCLA Oncology Center Los Angeles, California, United States
View all 84 locations
View Trial Details

Related conditions